Priyesh Mehta, DO
Pain Medicine · Dayton, OHNPI 1811284326
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,554 of the $16,055 with a category attached, or 72.0%. 37 manufacturers reported payments, led by Abbott at 50.2% of the total.
Across 466 payments — averaging $34.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$8K
- Relievant Medsystems, Inc.$2K
- Vertos Medical, Inc.$2K
- Vertiflex, Inc.$608
- Boston Scientific$606
- AbbVie$547
- plus $3K from 31 others
Across 261 payments — averaging $8447.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$636K
- Vertex$501K
- Eli Lilly$450K
- Mesoblast, Inc.$158K
- Seikagaku Corporation$147K
- Averitas Pharma Inc.$114K
- plus $198K from 9 others
What the payments were for
- Travel & lodging$4,46528%
- Food & beverage$11,55472%
- Education$360%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 215 | $8,062 |
| Relievant Medsystems, Inc. | 22 | $1,692 |
| Vertos Medical, Inc. | 21 | $1,607 |
| Vertiflex, Inc. | 6 | $608 |
| Boston Scientific | 15 | $606 |
| AbbVie(2 entities) | 28 | $547 |
| Collegium Pharmaceutical, Inc. | 32 | $436 |
| Medtronic(3 entities) | 13 | $415 |
| Curonix LLC | 14 | $408 |
| Bard Peripheral Vascular, Inc. | 19 | $375 |
| Amgen | 17 | $279 |
| Pfizer | 14 | $183 |
| Spinal Simplicity, LLC | 4 | $103 |
| Averitas Pharma Inc. | 5 | $84 |
| Lundbeck LLC | 3 | $58 |
| Novartis | 4 | $53 |
| Teva Pharmaceuticals USA, Inc. | 3 | $50 |
| Nalu Medical, Inc. | 2 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $41 |
| Scilex Pharmaceuticals Inc. | 3 | $41 |
| Lilly USA, LLC | 3 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $36 |
| Vertex | 1 | $29 |
| Venclose Inc. | 1 | $29 |
| Biotronik NRO, Inc. | 2 | $28 |
| Biohaven Pharmaceuticals, Inc. | 2 | $25 |
| Protega Pharmaceutials Inc | 1 | $25 |
| Globus Medical | 1 | $21 |
| Si-bone, Inc. | 1 | $20 |
| Convatec Inc. | 1 | $17 |
| Angiodynamics, Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Galderma Laboratories, L.p. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| GRT US Holding, Inc. | 1 | $12 |
| Cashflow Solutions, LLC | 1 | $12 |
| Daiichi Sankyo Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$4,381
- PROCLAIM$2,928
- Proclaim Family of SCS IPGs$1,386
- mild Device Kit$1,049
- Superion ISS$544
- SUPERION$125
- Axium INS DRG IPG$122
- Proclaim IPG$121
- PRODIGY$120
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$112
- ETERNA$104
How this compares
$16,055 in reported general payments places this provider in the 85th percentile of 245 pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 34 | $23,919 |
| UbrelvyUbrogepant | 11 | $15,245 |
| Hysingla ErHydrocodone Bitartrate | 16 | $14,198 |
| Xtampza ErOxycodone Myristate | 19 | $14,140 |
| BelbucaBuprenorphine Hcl | 14 | $7,806 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 328 | $6,803 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 281 | $5,749 |
| Buprenorphine | 21 | $4,934 |
| Pregabalin | 112 | $4,278 |
| Gabapentin | 290 | $2,809 |
| Lidocaine | 30 | $2,073 |
| Morphine Sulfate ErMorphine Sulfate | 62 | $2,017 |
| Celecoxib | 49 | $1,366 |
| Fentanyl | 15 | $1,311 |
| Tizanidine Hcl | 68 | $953 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $436 | $21,94633 claims |
| AbbVieUbrelvy | $547 | $15,24511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 245 pain medicine providers in Ohio.
Other pain medicine in Dayton
- Tammy DannDayton$431K
- Jonathan SilvermanDayton$234K
- Alexander EscobarToledo$638K
- Nagy MekhailCleveland$511K
- Henry VuceticWilloughby$509K
- Michael DankoLoveland$381K
- Tristan WeaverColumbus$202K
- Robert BolashCleveland$154K
- Dmitri SouzaCuyahoga Falls$61K
- Aman UpadhyayCleveland$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.